Genetic Technologies Limited
GNTLF
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -56.81% | -34.85% | -14.07% | -11.81% | -8.89% |
| Total Other Revenue | -14.60% | 1.78% | 17.75% | 2.78% | -9.55% |
| Total Revenue | -18.76% | -35.38% | -46.08% | -45.13% | -43.55% |
| Cost of Revenue | -10.76% | -39.61% | -54.80% | -51.44% | -47.14% |
| Gross Profit | -23.06% | -32.64% | -39.79% | -41.00% | -41.40% |
| SG&A Expenses | -0.63% | -18.11% | -30.37% | -35.54% | -39.68% |
| Depreciation & Amortization | -37.41% | -39.17% | -41.07% | -32.68% | -23.03% |
| Other Operating Expenses | -27.71% | -25.24% | -23.98% | -14.07% | -1.01% |
| Total Operating Expenses | -12.45% | -27.05% | -37.28% | -36.06% | -34.02% |
| Operating Income | 6.93% | 19.18% | 28.53% | 26.18% | 22.61% |
| Income Before Tax | -1.06% | 20.56% | 36.77% | 24.79% | 7.84% |
| Income Tax Expenses | -- | -- | -- | 97.03% | 94.36% |
| Earnings from Continuing Operations | -1.18% | 19.90% | 35.93% | 23.61% | 6.08% |
| Earnings from Discontinued Operations | 75.67% | -24.14% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.38% | 12.30% | 0.44% | -16.66% | -40.72% |
| EBIT | 6.93% | 19.18% | 28.53% | 26.18% | 22.61% |
| EBITDA | 8.72% | 20.64% | 29.80% | 26.32% | 21.42% |
| EPS Basic | 41.84% | 31.14% | 21.77% | 5.58% | -15.25% |
| Normalized Basic EPS | 24.12% | 37.46% | 45.99% | 41.40% | 35.91% |
| EPS Diluted | 41.84% | 31.14% | 21.77% | 5.58% | -15.25% |
| Normalized Diluted EPS | 24.12% | 37.46% | 45.99% | 41.40% | 35.91% |
| Average Basic Shares Outstanding | 29.87% | 30.13% | 30.42% | 26.54% | 22.29% |
| Average Diluted Shares Outstanding | 29.87% | 30.13% | 30.42% | 26.54% | 22.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |